Point of Care Diagnostics Market Analysis, Growth, Share - 2028
[Research Report] The point of care diagnostics market was valued at US$ 36,000.4 million in 2021 and is projected to reach US$ 82,958.3 million by 2028; it is expected to grow at a CAGR of 12.7% from 2021 to 2028.
Market Insights and Analyst View:
Point-of-care (POC) testing is a term that describes diagnostic testing which is performed in the patient’s unit rather than in the hospital’s central lab or outside reference lab. Point of care tests may be done on blood, urine, swabs from mucosal surfaces, or saliva. In the emergency department (ED), POC testing is typically performed by both ED technicians (EDTs) and nurses. In some jurisdictions, emergency medical services providers use POC tests in pre-hospital settings. Most hospitals have developed a rigorous quality process for their POC testing programs. Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates in disease diagnosis, monitoring, and management. It enables quick medical decisions, as the diseases can be diagnosed at a very early stage, and is an important criterion in preventing advanced disease types. This primarily leads to improved health outcomes for patients by enabling the early start of treatment. Recent advancements in biosensors, which is a critical component for point of care diagnostics is directly responsible for the bioanalytical performance of assay.
Growth Drivers and Challenges:
Point-of-care testing (POCT) plays a critical role in diagnosis, treatment, and prevention of infectious diseases. POC testing can be used to detect several major pathogens, including malarial parasites, human immunodeficiency virus (HIV), human papillomavirus (HPV), dengue, Ebola, and Zika viruses; and Mycobacterium tuberculosis (TB bacteria). HIV has infected over 38 million people worldwide; ~85% of this population resides in developing countries, which have a limited availability of clinical diagnostics and antiretroviral therapy (ART) monitoring platforms. To narrow down the diagnostic time, companies are developing POC test kits and reagents. For instance, Food and Drug Administration (FDA) has approved the ARCHITECT HIV Ag/Ab EIA, a fourth-generation assay, introduced by Abbott Laboratories. The increasing incidence of infectious diseases such as HIV is the major global public health issue. In 2019, World Health Organization (WHO) claimed that more than 38 million people were diagnosed with HIV, out of which 1.7 million people were newly diagnosed worldwide, including 62% adults and 54% children. According to a study published by UNAIDS, in 2019, around 690,000 people died because of HIV and associated conditions. As per the European Centre for Disease Prevention and Control, ~2 million people in Europe were infected with HIV in 2019. Moreover, healthcare-associated infections (HAIs) such as central line-associated bloodstream infections and catheter-associated urinary tract infections might affect the patients in hospitals and other healthcare facilities. According to a recent study published on NCBI in 2020, HAI causes around 16 million additional hospitalization days in Europe each year. Moreover, according to the same study, HAI leads to additional financial burden of around US$ 8.5 billion in Europe each year. In addition, according to the Office of Disease Prevention and Health Promotion, 1 out of 25 hospitalizations in the US suffers from HAI at any given time. Such increase in prevalence of infectious diseases is expected to create a demand for point of care tests kits across the world. Such a factor has assisted the growth of point of care diagnostics market and is expected to follow a similar trend during the forecast period.
Product recalls are rising in size and number in the industry, predominantly driven by the increasing complexity of global supply chains, as well as increasingly stringent regulations. In 2018, PTS Panels CHOL+GLU test strips, which are considered as in vitro diagnostic medical devices were recalled in Australia. The cause of recall was related to medical device activity. According to the Department of Health, these devices were manufactured by point-of-care Diagnostics Australia Pty Ltd. Based on the results of internal testing, there was malfunctioning in measurement of the glucose test. This issue may result in the delay in diagnosis of diabetes. Similarly, in April 2020, Trividia Health, Inc. issued a notice for nationwide voluntary recall for its TRUE METRIX AIR Blood Glucose Meter. The company issued this notice due to malfunctioning of measurement units in the glucose meter. Such events are anticipated to hamper the customer confidence toward the use of point of care devices, which will eventually deter the point of care tests market growth.
Moreover, turnaround time for molecular diagnostic tests is important in detecting infectious agents, in determining a patient's ability to metabolize a drug or drug class. This is also essential in detecting minimal residual disease. These applications would benefit from the development of a point-of-care device for nucleic acid extraction, amplification, and detection. The device would have a low cost per test, use a disposable unit use device for all steps in the assay, should be portable, and provide a result that requires no interpretation. The creation of such a device requires miniaturization of current technologies and the use of microfluidics, microarrays, and small-diameter capillary tubes to reduce reagent volumes. This will simplify heat conduction by convection during nucleic acid amplification. This ideal device may be available in in the coming years and will expand the global point of care molecular diagnostics market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Point of Care Diagnostics Market: Strategic Insights
Market Size Value in US$ 36,000.4 Million in 2021 Market Size Value by US$ 82,958.3 Million by 2028 Growth rate CAGR of 12.7% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Point of Care Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 36,000.4 Million in 2021 |
| Market Size Value by | US$ 82,958.3 Million by 2028 |
| Growth rate | CAGR of 12.7% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Point of Care Diagnostics Market” is segmented based on product, end user, prescription mode, and geography. Based on product, the point of care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker, cholesterol testing, urinalysis testing, hematology testing, and other testing products. Based on end user, the point of care diagnostics market is segmented into professional diagnostic centers, research laboratories, homecare, and others. Based on prescription mode, the point of care diagnostics market is bifurcated into OTC testing and prescription-based testing. The point of care diagnostics market based on geography is segmented into North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
Based on product, the point of care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic testing, pregnancy and fertility testing, coagulation testing, tumor/cancer marker, cholesterol testing, urinalysis testing, hematology testing, and other testing products. In 2020, the glucose monitoring product segment held the largest share of the market, whereas, infectious disease testing segment is anticipated to register the highest CAGR of 14.1% during the forecast period. The glucose monitoring devices market consists of components such as glucometers, lancets, testing strips and other glucose monitoring devices. In 2020, the testing strips segment held the largest market share among the glucose monitoring devices segments. The glucose monitoring devices or glucose meters are medical devices are used to determine the approximate levels or the concentration of glucose in the blood of the patients living with diabetes. The concentration of the glucose level can be measured by various means such as through testing strips, lancets and others. In the market various market players have introduced their devices for the glucose monitoring that includes Contour Net EZ, Accu-Check Aviva, Abbott FreeStyle, One Touch Verio. They are being offered by player/market participants such as Abbott, F. Hoffman-La Roche Ltd, and others. In addition, due to the rise in the technology advancements, the developments for the new products are offering various benefits to the user. For instance, diamontech GmbH has invented non-invasive glucose monitoring device. The company offers DMT Base, DMT Pocket and DMT Band that helps the diabetes patients for monitoring their glucose level. Therefore, owing to the presence of the various market players that are offering various products and rise in the technological advancements are likely to propel the growth of global point of care diagnostics market.
Infectious diseases are caused by microorganisms, such as bacteria, viruses, fungi, and parasites. Diagnostic test for an infectious agent is used to demonstrate the presence of the infection. Specimens such as urine, blood, sputum, cerebrospinal fluid, and others are subjected to various tests and the disease-causing bacteria and viruses, known as the infectious agents, are identified quickly.
Real-time test results are important for early diagnosis and in determining treatment orientation in medical practice. Point of Care Testing (POCT) provides beneficial and helpful information for diagnosis and treatment through real-time testing at the bedside. Hence, POCT has high utility value in field of infectious diseases. Infectious disease rapid test kits are widely available for a wide variety of prophlogistic pathogen targets, including bacterial, viral, fungal, protozoal, and other disease agents. In January 2023, Cipla Limited announced the launch of Cippoint, a point- of-care testing device. This state-of-the-art device offers a wide range of testing parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. The device is CE IVD approved. This essentially indicates that the device is approved by the European In-Vitro Diagnostic Device Directive, thus ensuring reliable testing solutions. With entry in these new segments, Cipla has expanded its product offerings for diagnostics laboratories and their goal is to bridge the current gap in the diagnostic ecosystem in India by providing accurate and reliable test methods at affordable prices.
Based on end use, the point of care diagnostics market is segmented into professional diagnostic centers, research laboratories, homecare, and others. In 2020, the professional diagnostic centers segment held the largest share of the market and is expected to witness a similar trend during the forecast period. However, the homecare segment is anticipated to register the highest CAGR of 13.3% during the forecast period. Patients can easily monitor their glucose levels at home and this essentially helps them in customizing their insulin therapy to manage their diabetes levels. During the pandemic situation, the homecare point of care diagnostics was at boom as this led to fewer hospital visits. Advancements such as telemedicine and technological advancements in point of care testing devices assisted the global market during the COVID-19 crisis.
Regional Analysis:
Based on geography, the point of care diagnostics market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest share of the point of care diagnostics market followed by Europe. Growing prevalence of infectious diseases, government support for advanced diagnostics kits and instruments, and increasing efforts in R&D activities undertaken by the market players operating in the market is expected to aid the regional growth. According to EBSCO Information Services, as of September 2020, more than 1,000 cases of Hepatitis A has been reported in each of these states: Florida, Georgia, Indiana, Kentucky, Ohio, Tennessee, and West Virginia. The number of cases reported since the arrival of COVID-19 has reached 6,358 (as of September 26, 2020), and with some of the current state outbreaks dating back to 2016, 2017, or 2018, the overall number has now exceeded 32,000 cases. Generally, Hepatitis A largely under control in the United States until three years ago, can be easily prevented through the use of a safe and effective vaccine. However, the number of reported cases has taken a dramatic up-turn during the current COVID-19 pandemic. During such situations, the point of care diagnostic solutions proved to be an effective solution for the patients as government organizations issued various rules and regulations to avoid social distancing owing to COVID-19. Lesser hospital visits were one of the main reasons that increased the demand for point of care tests. Such factors is expected to aid the point of care diagnostic tests market during the forecast period.
Point of Care Diagnostics Market Report Scope
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global point of care diagnostics market are listed below:
- In April 2019, Roche launched VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients.
- In April 2019, Bio-Rad Laboratories, Inc. received U.S. Food and Drug Administration (FDA) approval for its BioPlex 2200 Lyme Total Assay. This was an innovative multiplex test method for the diagnosis of Lyme disease.
Competitive Landscape and Key Companies:
Companies such as Roche, Bio-Rad, bioMérieux, Siemens Healthineers, Nova Biomedical, Danaher, PTS Diagnostics, and Abbott has been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized strategies such as product launch, product up-gradation, patents, expansion of their product portfolio and area expansion for the growth of their organizations. In addition, the companies have invested their efforts to develop products and have received approvals from regulatory bodies such as the US FDA for their products.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product , Prescription Mode , and End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Point of Care Diagnostics Market – By Product
1.3.2 Global Point of Care Diagnostics Market – By Prescription Mode
1.3.3 Global Point of Care Diagnostics Market – By End User
1.3.4 Global Point of Care Diagnostics Market – By Geography
2. Point of Care Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Point of Care Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
5. Global Point of Care Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Prevalence of Infectious Diseases
5.1.2 Product Launches and Product Developments
5.1.3 Rise in Number of CLIA-Waived POC Tests
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.3.2 Increasing Number of Conferences and Events
5.4 Future Trends
5.4.1 Rising Use of Home-Based POC Devices
5.5 Impact Analysis
6. Point of Care Diagnostics Market – Global Analysis
6.1 Global Point of Care Diagnostics Market Revenue Forecast and Analysis
6.2 Global Point of Care Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Point of Care Diagnostics Market Analysis– by Product
7.1 Overview
7.2 Global Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
7.3 Glucose Monitoring
7.3.1 Overview
7.3.2 Global Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Infectious Disease Testing Market
7.4.1 Overview
7.4.2 Global Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 HIV Testing Market
7.4.3.1 Overview
7.4.3.2 Global HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Influenza Testing
7.4.4.1 Overview
7.4.4.2 Global Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing
7.4.5.1 Overview
7.4.5.2 Global Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Hepatitis C Testing
7.4.6.1 Overview
7.4.6.2 Global Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing
7.4.7.1 Overview
7.4.7.2 Global Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.8 Tropical Disease Testing
7.4.8.1 Overview
7.4.8.2 Global Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.9 Respiratory Infection Testing
7.4.9.1 Overview
7.4.9.2 Global Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.10 Other Infectious Disease
7.4.10.1 Overview
7.4.10.2 Global Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Cardiometabolic Testing
7.5.1 Overview
7.5.2 Global Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Pregnancy and Fertility Testing
7.6.1 Overview
7.6.2 Global Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Coagulation Testing
7.7.1 Overview
7.7.2 Global Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.8 Tumor/Cancer Marker Testing
7.8.1 Overview
7.8.2 Global Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.9 Cholesterol Testing
7.9.1 Overview
7.9.2 Global Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.10 Urinalysis Testing
7.10.1 Overview
7.10.2 Global Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.11 Haematology Testing
7.11.1 Overview
7.11.2 Global Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
7.12 Other POC
7.12.1 Overview
7.12.2 Global Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
8. Global Point of Care Diagnostics Market Analysis– by Prescription Mode
8.1 Overview
8.2 Global Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Global Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 OTC Testing Market
8.4.1.1 Overview
8.4.1.2 Global OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
9. Global Point of Care Diagnostics Market Analysis– by End User
9.1 Overview
9.2 Global Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
9.3 Professional Diagnostic Centers Market
9.3.1 Overview
9.3.2 Global Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Hospitals Market
9.3.3.1 Overview
9.3.3.2 Global Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.4 Clinical Laboratories
9.3.4.1 Overview
9.3.4.2 Global Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5 Outpatient Healthcare Market
9.3.5.1 Overview
9.3.5.2 Global Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.6 Ambulatory Care Settings Market
9.3.6.1 Overview
9.3.6.2 Global Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Home Care Market
9.4.1 Overview
9.4.2 Global Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Research Laboratories Market
9.5.1 Overview
9.5.2 Global Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.6 Others Market
9.6.1 Overview
9.6.2 Global Others Market Revenue and Forecasts to 2028 (US$ Mn)
10. Global Point of Care Diagnostics Market - Geographical Analysis
10.1 North America: Point of Care Diagnostics Market
10.1.1 Overview
10.1.2 North America: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Point of Care Diagnostics Market - By Product, 2019-2028 (USD Million)
10.1.3.1 North America: Infectious Disease Testing Products Market - By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.4 North America: Point of Care Diagnostics Market - By Prescription Mode, 2019-2028 (USD Million)
10.1.5 North America: Point of Care Diagnostics Market - By End User, 2019-2028 (USD Million)
10.1.5.1 North America: Professional Diagnostic Centres Market - By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.6 North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.1.7 US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.1 US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.7.2 US: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.7.2.1 US: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.7.3 US: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.7.4 US: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.7.4.1 US: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.8 Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Canada: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.8.2.1 Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.8.3 Canada: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.8.4 Canada: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.8.4.1 Canada: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.9 Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.9.1 Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.9.2 Mexico: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.9.2.1 Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.9.3 Mexico: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.9.4 Mexico: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.9.4.1 Mexico: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.2 Europe: Point of Care Diagnostics Market
10.2.1 Overview
10.2.2 Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Point of Care Diagnostics Market - By Product, 2019-2028 (USD Million)
10.2.3.1 Europe: Infectious Disease Testing Products Market - By Infectious Disease Testing, 2019-2028 (USD Million)
10.2.4 Europe: Point of Care Diagnostics Market - By Prescription Mode, 2019-2028 (USD Million)
10.2.5 Europe: Point of Care Diagnostics Market - By End User, 2019-2028 (USD Million)
10.2.5.1 Europe: Professional Diagnostic Centres Market - By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.2.6 Europe: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.2.7 UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.7.1 UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.7.2 UK: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.2.7.2.1 UK: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.2.7.3 UK: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.2.7.4 UK: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.2.7.4.1 UK: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.2.8 Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.8.1 Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.8.2 Germany: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.2.8.2.1 Germany: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.2.8.3 Germany: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.2.8.4 Germany: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.2.8.4.1 Germany: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.2.9 France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.9.1 France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.9.2 France: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.2.9.2.1 France: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.2.9.3 France: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.2.9.4 France: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.2.9.4.1 France: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.2.10 Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.10.1 Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.10.2 Italy: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.2.10.2.1 Italy: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.2.10.3 Italy: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.2.10.4 Italy: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.2.10.4.1 Italy: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.2.11 Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.11.1 Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.11.2 Spain: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.2.11.2.1 Spain: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.2.11.3 Spain: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.2.11.4 Spain: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.2.11.4.1 Spain: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.2.12 Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.12.1 Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.2.12.2 Rest of Europe: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.2.12.2.1 Rest of Europe: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.2.12.3 Rest of Europe: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.2.12.4 Rest of Europe: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.2.12.4.1 Rest of Europe: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.3 Asia Pacific: Point of Care Diagnostics Market
10.3.1 Overview
10.3.2 Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Point of Care Diagnostics Market - By Product, 2019-2028 (USD Million)
10.3.3.1 Asia Pacific: Infectious Disease Testing Products Market - By Infectious Disease Testing, 2019-2028 (USD Million)
10.3.4 Asia Pacific: Point of Care Diagnostics Market - By Prescription Mode, 2019-2028 (USD Million)
10.3.5 Asia Pacific: Point of Care Diagnostics Market - By End User, 2019-2028 (USD Million)
10.3.5.1 Asia Pacific: Professional Diagnostic Centres Market - By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.3.6 Asia Pacific: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.3.7 Japan: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.7.1 Japan: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.7.2 Japan: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.3.7.2.1 Japan: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.3.7.3 Japan: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.3.7.4 Japan: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.3.7.4.1 Japan: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.3.8 China: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.8.1 China: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.8.2 China: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.3.8.2.1 China: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.3.8.3 China: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.3.8.4 China: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.3.8.4.1 China: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.3.9 India: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.9.1 India: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.9.2 India: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.3.9.2.1 India: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.3.9.3 India: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.3.9.4 India: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.3.9.4.1 India: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.3.10 South Korea: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.10.1 South Korea: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.10.2 South Korea: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.3.10.2.1 South Korea: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.3.10.3 South Korea: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.3.10.4 South Korea: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.3.10.4.1 South Korea: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.3.11 Australia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.11.1 Australia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.11.2 Australia: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.3.11.2.1 Australia: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.3.11.3 Australia: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.3.11.4 Australia: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.3.11.4.1 Australia: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.3.12 Rest of Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.12.1 Rest of Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.3.12.2 Rest of Asia Pacific: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.3.12.2.1 Rest of Asia Pacific: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.3.12.3 Rest of Asia Pacific: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.3.12.4 Rest of Asia Pacific: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.3.12.4.1 Rest of Asia Pacific: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.4 Middle East & Africa: Point of care Diagnostics Market
10.4.1 Overview
10.4.2 Middle East & Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East and Africa: Point of Care Diagnostics Market - By Product, 2019-2028 (USD Million)
10.4.3.1 Middle East and Africa: Infectious Disease Testing Products Market - By Infectious Disease Testing, 2019-2028 (USD Million)
10.4.4 Middle East and Africa: Point of Care Diagnostics Market - By Prescription Mode, 2019-2028 (USD Million)
10.4.5 Middle East and Africa: Point of Care Diagnostics Market - By End User, 2019-2028 (USD Million)
10.4.5.1 Middle East and Africa: Professional Diagnostic Centres Market - By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.4.6 Middle East & Africa: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.4.7 UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.7.1 UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.7.2 UAE: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.4.7.2.1 UAE: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.4.7.3 UAE: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.4.7.4 UAE: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.4.7.4.1 UAE: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.4.8 Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.8.1 Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.8.2 Saudi Arabia: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.4.8.2.1 Saudi Arabia: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.4.8.3 Saudi Arabia: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.4.8.4 Saudi Arabia: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.4.8.4.1 Saudi Arabia: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.4.9 South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.9.1 South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.9.2 South Africa: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.4.9.2.1 South Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.4.9.3 South Africa: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.4.9.4 South Africa: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.4.9.4.1 South Africa: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.4.10 Rest of Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.4.10.2.1 Rest of Middle East and Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.4.10.4.1 Rest of Middle East and Africa: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.5 South and Central America: Point of Care Diagnostics Market
10.5.1 Overview
10.5.2 South and Central America: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Point of Care Diagnostics Market - By Product, 2019-2028 (USD Million)
10.5.3.1 South and Central America: Infectious Disease Testing Products Market - By Infectious Disease Testing, 2019-2028 (USD Million)
10.5.4 South and Central America: Point of Care Diagnostics Market - By Prescription Mode, 2019-2028 (USD Million)
10.5.5 South and Central America: Point of Care Diagnostics Market - By End User, 2019-2028 (USD Million)
10.5.5.1 South and Central America: Professional Diagnostic Centres Market - By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.5.6 South and Central America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.5.7 Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5.7.1 Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5.7.2 Argentina: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.5.7.2.1 Argentina: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.5.7.3 Argentina: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.5.7.4 Argentina: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.5.7.4.1 Argentina: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.5.8 Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5.8.1 Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5.8.2 Brazil: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.5.8.2.1 Brazil: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.5.8.3 Brazil: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.5.8.4 Brazil: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.5.8.4.1 Brazil: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.5.9 Rest of South and Central America: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5.9.1 Rest of South and Central America: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.5.9.2 Rest of South and Central America: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.5.9.2.1 Rest of South and Central America: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.5.9.3 Rest of South and Central America: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.5.9.4 Rest of South and Central America: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.5.9.4.1 Rest of South and Central America: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Point of Care Diagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Point of Care Diagnostics Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Point of Care Diagnostics Market, 2018-2021
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Nova Biomedical
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 4. North America: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 5. North America: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 6. US: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 7. US: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 8. US: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 9. US: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 10. US: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 14. Canada: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 15. Canada: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 21. Europe: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 22. Europe: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 23. Europe: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 24. Europe: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 25. Europe: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 26. UK: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 27. UK: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 28. UK: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 30. UK: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 31. Germany: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 32. Germany: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 33. Germany: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 34. Germany: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 35. Germany: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 36. France: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 37. France: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 38. France: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 39. France: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 40. France: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 41. Italy: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 42. Italy: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 43. Italy: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 44. Italy: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 45. Italy: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 46. Spain: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 47. Spain: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 48. Spain: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 49. Spain: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 50. Spain: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Europe: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 61. Japan: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 62. Japan: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 63. Japan: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 64. Japan: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 65. Japan: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 66. China: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 67. China: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 68. China: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 69. China: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 70. China: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 71. India: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 72. India: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 73. India: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 74. India: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 75. India: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 76. South Korea: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 81. Australia: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 82. Australia: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 83. Australia: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 84. Australia: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 85. Australia: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 86. Rest of Asia Pacific: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 91. Middle East and Africa: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East and Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East and Africa: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East and Africa: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East and Africa: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 96. UAE: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 97. UAE: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 98. UAE: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 99. UAE: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 100. UAE: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 101. Saudi Arabia: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 102. Saudi Arabia: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 103. Saudi Arabia: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 104. Saudi Arabia: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 105. Saudi Arabia: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 106. South Africa: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 111. Rest of Middle East and Africa: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 116. South and Central America: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America: Professional Diagnostic Centers Market, By Professional Diagnostic Centers - Revenue and Forecast to 2028 (USD Million)
Table 121. Argentina: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 122. Argentina: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 123. Argentina: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 124. Argentina: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 125. Argentina: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 126. Brazil: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 127. Brazil: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 128. Brazil: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 129. Brazil: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 130. Brazil: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South and Central America: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 136. Recent Organic Developments the Point of Care Diagnostics Market
Table 137. Recent Inorganic Developments in the Point of Care Diagnostics Market
Table 138. Glossary of Terms, Point of Care Diagnostics Market
LIST OF FIGURES
Figure 1. Point of Care Diagnostics Market Segmentation
Figure 2. Point of Care Diagnostics Market Segmentation, By Region
Figure 3. Point of Care Diagnostics Market Overview
Figure 4. Prescription-Based Testing Segment Held Largest Share of Point of Care Diagnostics Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Point of Care Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Point of Care Diagnostics Market – Leading Country Markets (US$ Million)
Figure 8. Global Point of Care Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis of Driver and Restraints Pertaining to Point of Care Diagnostics Market
Figure 15. Global Point of Care Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Point of Care Diagnostics Market – By Geography Forecast and Analysis – 2020- 2028
Figure 17. Market Positioning of Key Players in Global Point of Care Diagnostics Market
Figure 18. Global Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
Figure 19. Global Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. Global Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. Global HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. Global Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. Global Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. Global Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. Global Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. Global Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. Global Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. Global Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. Global Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. Global Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. Global Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. Global Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. Global Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. Global Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. Global Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. Global Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. Global Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
Figure 38. Global Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. Global OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. Global Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
Figure 41. Global Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. Global Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 43. Global Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 44. Global Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. Global Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46. Global Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 47. Global Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 48. Global Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 49. North America: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 50. North America: Point of Care Diagnostics Market - Revenue and Forecasts to 2028 (USD Million)
Figure 51. North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 52. US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. Mexico Point of care diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
Figure 55. Europe: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 56. Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. Europe: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 58. UK: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 59. Germany: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 60. France: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 61. Italy: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 62. Spain: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 63. Rest of Europe: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 64. Asia Pacific: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 65. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 66. Asia Pacific: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 67. Japan: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. China: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 69. India: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 70. South Korea: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 71. Australia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 72. Rest of Asia Pacific: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 73. Middle East & Africa: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 74. Middle East & Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 75. Middle East & Africa: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 76. UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 77. Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 78. South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 79. Rest of Middle East and Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 80. South and Central America: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 81. South and Central America: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 82. South and Central America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 83. Argentina: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 84. Brazil: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 85. Rest of South and Central America: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 86. Impact of COVID-19 Pandemic in North American Country Markets
Figure 87. Impact of COVID-19 Pandemic in European Country Markets
Figure 88. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 89. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 90. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 91. Growth Strategies in the Point of Care Diagnostics Market, 2018-2021
The List of Companies - Point of Care Diagnostics Market
- F. Hoffmann-La Roche Ltd
- Abbott
- bioMérieux SA
- Johnson & Johnson Services, Inc.
- Nova Biomedical
- Siemens AG
- Bio Rad Laboratories Inc.
- BD
- Danaher Corporation
- PTS Diagnostics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For